Zurit Levine
Chief Tech/Sci/R&D Officer chez COMPUGEN LTD.
Profil
Zurit Levine is currently the Vice President-Technology Innovation at Compugen Ltd.
Prior to this role, Dr. Levine held positions as Director at Neviah Genomics Ltd.
and Therapeutic Discovery Corp.
Dr. Levine has an educational background that includes undergraduate, graduate, and doctorate degrees from Tel-Aviv University.
Postes actifs de Zurit Levine
| Sociétés | Poste | Début |
|---|---|---|
| COMPUGEN LTD. | Chief Tech/Sci/R&D Officer | 01/01/2018 |
Anciens postes connus de Zurit Levine
| Sociétés | Poste | Fin |
|---|---|---|
Therapeutic Discovery Corp.
 Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA. | Director/Board Member | 01/01/2007 |
Neviah Genomics Ltd.
 Neviah Genomics Ltd. Pharmaceuticals: MajorHealth Technology Neviah Genomics Ltd. develops novel biomarkers for the prediction of drug-induced toxicity. It identifies biomarkers for the prediction of drug-induced toxicity. The firm offers involving cell harvest and culture, compound exposure, mRNA expression analysis and multi-parameter mathematical computation. The company was founded in 2012 and is headquartered in Yavne, Israel. | Director/Board Member | - |
Formation de Zurit Levine
| Tel-Aviv University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| COMPUGEN LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Therapeutic Discovery Corp.
Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA. | Health Technology |
Neviah Genomics Ltd.
Neviah Genomics Ltd. Pharmaceuticals: MajorHealth Technology Neviah Genomics Ltd. develops novel biomarkers for the prediction of drug-induced toxicity. It identifies biomarkers for the prediction of drug-induced toxicity. The firm offers involving cell harvest and culture, compound exposure, mRNA expression analysis and multi-parameter mathematical computation. The company was founded in 2012 and is headquartered in Yavne, Israel. | Health Technology |
